Glucagon-like peptide-1 receptor agonist treatment of high carbohydrate intake-induced metabolic syndrome provides pleiotropic effects on cardiac dysfunction through alleviations in electrical and intracellular Ca2+ abnormalities and mitochondrial dysfunction


DURAK A., AKKUŞ E., GÖKÇAY CANPOLAT A., TUNCAY E., ÇORAPÇIOĞLU D., Turan B.

Clinical and Experimental Pharmacology and Physiology, vol.49, no.1, pp.46-59, 2022 (Journal Indexed in SCI Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 49 Issue: 1
  • Publication Date: 2022
  • Doi Number: 10.1111/1440-1681.13590
  • Title of Journal : Clinical and Experimental Pharmacology and Physiology
  • Page Numbers: pp.46-59
  • Keywords: arrhythmia, electrical activity, insulin resistance, ion-homeostasis, sodium-calcium exchanger, LEFT-VENTRICULAR FUNCTION, HEART-FAILURE, RYANODINE RECEPTOR, OXIDATIVE STRESS, PKA PHOSPHORYLATION, NATRIURETIC-PEPTIDE, GLP-1 RECEPTOR, GLUCOSE-UPTAKE, LIRAGLUTIDE, CALCIUM

Abstract

© 2021 John Wiley & Sons Australia, Ltd.The pleiotropic effects of glucagon-like peptide-1 receptor (GLP-1R) agonists on the heart have been recognised in obese or diabetic patients. However, little is known regarding the molecular mechanisms of these agonists in cardioprotective actions under metabolic disturbances. We evaluated the effects of GLP-1R agonist liraglutide treatment on left ventricular cardiomyocytes from high-carbohydrate induced metabolic syndrome rats (MetS rats), characterised with insulin resistance and cardiac dysfunction with a long-QT. Liraglutide (0.3 mg/kg for 4 weeks) treatment of MetS rats significantly reversed long-QT, through a shortening the prolonged action potential duration and recovering inhibited K+-currents. We also determined a significant recovery in the leaky sarcoplasmic reticulum (SR) and high cytosolic Ca2+-level, which are confirmed with a full recovery in activated Na+/Ca2+-exchanger currents (INCX). Moreover, the liraglutide treatment significantly reversed the depolarised mitochondrial membrane potential (MMP), increased production of oxidant markers, and cellular acidification together with the depressed ATP production. Our light microscopy analysis of isolated cardiomyocytes showed marked recoveries in the liraglutide-treated MetS group such as marked reverses in highly dilated T-tubules and SR-mitochondria junctions. Moreover, we determined a significant increase in depressed GLUT4 protein level in liraglutide-treated MetS group, possibly associated with recovery in casein kinase 2α. Overall, the study demonstrated a molecular mechanism of liraglutide-induced cardioprotection in MetS rats, at most, via its pleiotropic effects, such as alleviation in the electrical abnormalities, Ca2+-homeostasis, and mitochondrial dysfunction in ventricular cardiomyocytes.